NEXGEL Adds Sequence Executives to Board After Deal Financing
LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) appointed Sequence LifeScience executives Brian Kieser and Kevin Harris to its board following a recent financing tied to NEXGEL’s acquisition of a degenerative …
NEXGEL Adds Sequence Executives to Board After Deal Financing Read More